Abstract
Background: Despite the increased reporting of tramadol poisoning, the nature and toxicology of tramadol-associated deaths have not been adequately subjected to systematic evaluation. This study aims to investigate the causes, nature and toxicology of tramadol-associated deaths by systematically reviewing the case studies and case series published in peer-reviewed journals.
Methods: Scopus, Embase, Medline and Google Scholar were searched from inception until 30 May 2020 to identify the case studies and case series published in English that reported tramadol-associated deaths. Data on number of deaths, routes of administration, toxicological data and any concomitant drug usage were extracted. The Joanna Briggs Institute’s quality assessment tool was used to assess the quality of included studies.
Results: The initial searches identified 451 articles. Of these, 12 studies (eight case studies and four case series) were considered in the review, which represented a total of 181 deaths, with UK (n = 127) and Sweden (n = 17) reporting most deaths. Intentional suicide was the cause of tramadol poisoning in 54 of the 181 cases. Data on routes of administration were often missing; however, the most common related was the oral route (15.5%). Mixed drug toxicity was among the causes of reported deaths (n = 127, 70.2%), where in most cases, individuals were receiving other central nervous system depressants, especially benzodiazepines. However, tramadol, as the sole cause of death, was reported in eight cases. The mean level of blood tramadol for the deaths was 10.6 µg/mL.
Conclusion: The unintentional nature of many tramadol deaths has been reported, and it is important to consider that the drug can be acquired through illicit means. Healthcare practitioners need to build a strong understanding about tramadol’s possible toxicity and should exercise caution when a patient is to use tramadol in combination with other drugs.
Methods: Scopus, Embase, Medline and Google Scholar were searched from inception until 30 May 2020 to identify the case studies and case series published in English that reported tramadol-associated deaths. Data on number of deaths, routes of administration, toxicological data and any concomitant drug usage were extracted. The Joanna Briggs Institute’s quality assessment tool was used to assess the quality of included studies.
Results: The initial searches identified 451 articles. Of these, 12 studies (eight case studies and four case series) were considered in the review, which represented a total of 181 deaths, with UK (n = 127) and Sweden (n = 17) reporting most deaths. Intentional suicide was the cause of tramadol poisoning in 54 of the 181 cases. Data on routes of administration were often missing; however, the most common related was the oral route (15.5%). Mixed drug toxicity was among the causes of reported deaths (n = 127, 70.2%), where in most cases, individuals were receiving other central nervous system depressants, especially benzodiazepines. However, tramadol, as the sole cause of death, was reported in eight cases. The mean level of blood tramadol for the deaths was 10.6 µg/mL.
Conclusion: The unintentional nature of many tramadol deaths has been reported, and it is important to consider that the drug can be acquired through illicit means. Healthcare practitioners need to build a strong understanding about tramadol’s possible toxicity and should exercise caution when a patient is to use tramadol in combination with other drugs.
| Original language | English |
|---|---|
| Pages (from-to) | 422–432 |
| Number of pages | 11 |
| Journal | Drugs & Therapy Perspectives |
| Volume | 37 |
| Issue number | 9 |
| Early online date | 6 Aug 2021 |
| DOIs | |
| Publication status | Published - Sept 2021 |
Bibliographical note
Publisher Copyright:© 2021, The Author(s), under exclusive licence to Springer Nature Switzerland AG.
ASJC Scopus subject areas
- Pharmacology (medical)